CRC Transregio 221|Projects

Project IRTG

 

Integrated Research Training Group of the CRC/TR221.

Principal Investigators: Prof. Dr. med. Matthias Edinger, PD Dr. med. Anita Kremer, PD Dr. rer. nat. Friederike Berberich-Siebelt

Summary Project IRTG

The Integrated Research Training Group (IRTG) of the CRC/TR 221 supports the participating MDs and PhD students of the program by providing well-structured and interdisciplinary training and qualification modules. The program focusses on basic and translational science in the area of allogeneic hematopoietic stem cell transplantation and cell therapy, but covers all topics and technologies of current biomedical research. Through close supervision and mentoring programs the students are well supported for a successful graduation in an innovative research field.

 

Contact to Principal Investigators

  • Prof. Dr. Matthias Edinger
    University Hospital Regensburg
    Department of Internal Medicine III
    Franz-Josef-Strauß-Allee 11
    93053 Regensburg
    T: +49 941 944-5580
    matthias.edinger(at)ukr.de

  • PD Dr. Anita Kremer
    University Hospital Erlangen
    Department of Medicine 5
    Ulmenweg 18
    91054 Erlangen
    T: +49 9131 85-43183
    anita.kremer(at)uk-erlangen.de

  • PD Dr. Friederike Berberich-Siebelt
    University Würzburg
    Institute for Pathology
    Josef-Schneider-Str. 2
    97080 Würzburg
    T: +49 931 3181208
    path230@mail.uni-wuerzburg.de

Project INF

 

Data integration platform and systems medicine efforts to foster GvL and GvHD research

Principal Investigator: Prof. Dr. med. Thomas Dandekar, Prof. Dr. med. Ernst Holler, Prof. Dr. rer. nat. Birte Kehr, Dr. rer. nat. Meik Kunz

Site: Regensburg, Erlangen, Würzburg

Project INF

The INF project represents the data infrastructure project. It focuses mainly on data   management and sustained storage of all publication relevant scientific data. We also support the individual projects with adequate software and expert knowledge during the entire data analysis process. Our long-term aim is that the increasing amount of research data generated by the numerous immunologists, physicians and other scientists at the TR 221 sites Regensburg, Erlangen and Würzburg ultimately help to find new ways and tools that make allogeneic hematopoietic stem cell transplantation a more safe and effective treatment procedure, particularly by reducing transplant complications and relapse rates in patients. The INF project is financed during the first funding period by funds from the free state of Bavaria.

 

Contact to Principal Investigator


  • Prof. Dr. med. Ernst Holler
    University Hospital Regensburg
    Department of Internal Medicine III
    Franz-Josef-Strauss-Allee 11
    93053 Regensburg
    T: +49 941 943 5935
    ernst.holler(at)ukr.de

  • Prof. Dr. rer. nat. Birte Kehr
    LIT - Leibniz Institute for Immunotherapy (former RCI)      
    c/o Universitätsklinikum Regensburg
    Franz-Josef-Strauß-Allee 11
    93053 Regensburg
    T: +49 941 944 18161
    birte.kehr(at)ukr.de

  • Dr. rer. nat. Meik Kunz
    FAU Erlangen-Nürnberg
    Wetterkreuz 15
    91058 Erlangen
    T: +49 9131 8567784  
    meik.kunz(at)fau.de

Project Z01

 

Pathology work-up of GvL and GvHD in mice and men.

Principal Investigators: Prof. Dr. med. Matthias Evert, Prof. Dr. med. Maike Büttner-Herold, Prof. Dr. med. Andreas Rosenwald

Summary Project Z01

GvHD diagnosis is still a challenge even for experienced transplant pathologists due to its variable clinical and histological manifestation and the still insufficient validity and reproducibility of diagnostic histopathological criteria. In this service project, expert (immuno-)histological evaluation of human and murine tissues is provided. Furthermore, a digital histology archive will be established that includes consensus reports generated in virtual microscopy conferences and that are linked to clinical data bases for the evaluation of transplant outcome, complications and prognostic histology biomarkers.

 

Contact to Principal Investigators

  • Prof. Dr. Matthias Evert
    University Regensburg
    Department of Pathology
    Franz-Josef-Strauß-Allee 11
    93053 Regensburg
    T: +49 941 944-6600
    matthias.evert(at)ukr.de

  • Prof. Dr. med. Maike Büttner-Herold
    University Hospital Erlangen
    Department of Nephropathology
    Krankenhausstraße 8-10
    91054 Erlangen
    T: +49 9131 85-22605
    maike.buettner(at)uk-erlangen.de

  • Prof. Dr. med. Andreas Rosenwald
    Julius-Maximilians-University Würzburg
    Department of Pathology
    Josef-Schneider-Str. 2
    97080 Würzburg
    T: +49 931 31-81199
    rosenwald(at)uni-wuerzburg.de

Project Z02

 

Animal engineering and complex transplantation models.

Principal Investigators: PD Dr. rer. nat. Petra Hoffmann, Prof. Dr. rer. nat. Thomas Winkler, Prof. Dr. med. Dr. med. univ. Andreas Beilhack

Summary Project Z02

Due to the complexity of graft-versus-host (GvH) and graft-versus-leukemia (GvL) reactions their basic biology as well as novel intervention strategies can only be examined in adequate preclinical in vivo models. In addition to providing general support in all experimental and regulatory issues, the Z02 service project will generate valuable new genetically modified mouse strains for the consortium and provide an experimental platform permitting the investigation of GvHD in germ-free and gnotobiotic mice. We aim for highly informative, cross-validated, reproducible and predictive in vivo models at the three participating centers.

 

Contact to Principal Investigators

  • PD Dr. rer. nat. Petra Hoffmann
    University Hospital Regensburg
    Department of Internal Medicine III
    LIT - Leibniz Institute for Immunotherapy (former RCI)
    Franz-Josef-Strauß-Allee 11
    93053 Regensburg
    T: +49 941 944-5592
    petra.hoffmann(at)ukr.de

  • Prof. Dr. rer. nat. Thomas Winkler
    FAU Erlangen-Nürnberg
    Department of Biology
    Nikolaus-Fiebiger-Center for Molecular Medicine
    Glückstraße 6
    91054 Erlangen
    T: +49 9131 85-29136
    thomas.winkler(at)fau.de

  • Prof. Dr. med. Dr. med. univ. Andreas Beilhack
    University Hospital Würzburg
    Department of Medicine II
    ZEMM Center for Experimental Molecular Medicine
    Zinklesweg 10
    97078 Würzburg
    T: +49 931 201-44040
    beilhack_a(at)ukw.de

Project Z03

 

Central administration of the SFB Transregio 221

Principal Investigator: Prof. Dr. med. Wolfgang Herr

Summary Project Z03

The central administrative project takes care of the administrative and organizational matters of the CRC/TR 221. It manages the funds that are primarily used for the (i) recruitment and early career support of excellent young postdocs, (ii) rotation („Gerok“) positions for clinical principal investigators and young MD scientists, (iii) gender equality measures, (iv) support of new projects that have the potential to advance the CRC/TR program, (v) establishment and maintenance of a central biomaterial repository, (vi) project-specific workshops and guest speaker seminars, (vii)  traveling, (viii) public relation work.

 

Contact to Principal Investigator

  • Prof. Dr. med. Wolfgang Herr
    University Hospital Regensburg
    Department of Internal Medicine III
    Franz-Josef-Strauß-Allee 11
    93053 Regensburg
    T: +49 941 941-5501
    wolfgang.herr(at)ukr.de